The effect of novel synthetic communities on plant shoot Pi content can be predicted by an NN. by Sur Herrera Paredes (674875)

“…<p>(<b>A</b>) Schematic representation of the NN defined and applied for predictions. …”

The sialidase inhibitor Neu5Ac2en decreases growth of wt <i>C. canimorsus 5</i> in presence of macrophages. by Manuela Mally (348810)

Decreased tumorigenicity of Daoy cells over-expressing miR-199b-5p. by Livia Garzia (266719)

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Cardamonin decreased the protein expression of lipogenic proteins. by Peiguang Niu (17044532)

The number of different metabolites at each time point^b'*'. by Xi-Meng Sun (17721428)

Acoustic or tactile startle responses [V_max (mean ± SEM)] with or without acoustic or light prepulses. by Michael T. Williams (357796)

Means and SD of driving anger expression items now and five years ago (n = 774). by Amanda N. Stephens (5193431)

Mean and standard deviation of 5-point experience sampling scales for each group (treatment and control) and session (pre and post). by Julio Rodriguez-Larios (18778803)

Metabolite concentrations decrease to near-uninfected levels after treatment of infection. by Derick N. M. Osakunor (4839597)

Leukocyte infiltration <i>in vivo</i> is decreased by CLEC9A inhibition with H37Ra. by An-Chieh Cheng (4532641)

Decrease of bnAb activity during cell-cell transmission is variable and strain-dependent. by Lucia Reh (546554)

Effects of tolvaptan on brain water content (BWC), plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…(<b>B</b>) ChIP analysis of <i>PC3</i> binding to the <i>Id3</i> promoter in PC12 cells, treated as shown in (<b>A</b>). A scheme above the graph describes the <i>Id3</i> gene and the promoter region analyzed, 700 nt 5′ to the transcription start. …”

PowerPoint Slides for: Plasma Exchange as an Adjunctive Therapy for Crescentic IgA Nephropathy by Xie X. (2945913)

“…It also significantly decreased plasma IgA-IgG complex levels (pre-PE: 85.3 ± 25.9% vs. post-PE: 38.4 ± 12.4%, p < 0.001) and plasma and urinary active complement product levels, including C3a, C5a and soluble C5b-9. …”

Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

“…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”

Percentage decrease in the response time (mean ± std) in the post-training test phase when compared to that in the pre-training phase. by Lilian Fautrelle (711885)

A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity by Laura B Goodman (80305)

Metalloproteinase gene expression at different time points expressed as ΔCt. by Fabíola S. Z. Robertoni (751356)

P-V Fit Scores Across Demographic Factors Among 636 residents. by Yaotian Fan (5917766)

Subjects: